logo

Exhibiting at FOOD INGREDIENTS CHINA 2025

21M51
NECC (Shanghai)
17 Mar - 19 Mar, 2025

Product Offerings

Products:

Morinaga Milk Industry (Shanghai) Co., Ltd. is the China-based subsidiary of Morinaga Milk Industry Co., Ltd., one of Japan’s largest and most established dairy companies. As part of its strategic international expansion, the Shanghai entity plays a key role in strengthening the group’s operations, distribution, and product adaptation for the Chinese and wider Asia-Pacific markets.

Parent Company Overview

Founded in 1917, Morinaga Milk Industry Co., Ltd. is a Tokyo Stock Exchange-listed company (TSE: 2264) and a recognized leader in dairy innovation. The company reported consolidated net sales of JPY 646.3 billion (approximately USD 4.8 billion) in FY2023. Morinaga's diversified portfolio includes milk, infant formula, yogurt, cheese, functional foods, and health supplements, with a growing focus on overseas markets.

Core Business of the Shanghai Subsidiary

Morinaga Milk Industry (Shanghai) Co., Ltd. functions as a manufacturing and marketing hub for the group’s dairy and health-related products in China. The subsidiary primarily focuses on:

  • Localization of Morinaga’s global product lines
  • Regulatory compliance for Chinese food safety standards
  • Market research and consumer insights for the Chinese dairy market
  • Strategic partnerships with e-commerce platforms and distributors

Product Categories (Based on Morinaga's Global Portfolio)

While specific product listings under the Shanghai subsidiary are limited, Morinaga’s typical offerings in Asia include:

  • Infant Formula and Follow-up Milk Powders
  • Probiotic Yogurts and Drinks
  • Functional Beverages (e.g., iron, calcium, and lactoferrin-enriched)
  • Milk-based Desserts and Snacks
  • Nutritional Supplements

The Shanghai office supports the import, adaptation, and marketing of these products for Chinese consumers, often through co-manufacturing agreements and distribution alliances.

Localization and Market Adaptation

Morinaga Milk has adopted a localized brand strategy in China, customizing its packaging, flavors, and nutritional composition to align with local tastes and dietary guidelines. The Shanghai subsidiary works closely with Chinese regulatory bodies such as the SAMR (State Administration for Market Regulation) to ensure compliance with food labeling, ingredient sourcing, and infant formula registration protocols.

Strategic Initiatives in China

  • Launched the E-Akachan formula brand for Chinese infants, positioned as a premium Japanese import
  • Partnered with leading Chinese e-commerce platforms like JD.com and Tmall for online sales
  • Established research collaborations with Chinese nutrition institutes for clinical validation of products

Business Performance and Market Share

While subsidiary-level financials are undisclosed, Morinaga’s global financial reports note that:

  • Overseas sales reached JPY 50.2 billion (USD 373 million) in FY2023
  • China remains a key growth driver, especially in infant nutrition and health foods
  • Infant formula from Japan continues to enjoy strong brand trust among Chinese parents, boosting Morinaga’s exports and brand recognition

Certifications and Compliance

The company maintains strict quality standards across its operations, supported by certifications such as:

  • ISO 9001 / ISO 22000 for quality and food safety management
  • HACCP and GMP protocols for dairy processing
  • Registration under China’s SAMR infant formula approval system
  • Compliance with China’s National Food Safety Standards (GB standards)

Reputation and Brand Trust

Morinaga has built a reputation in China as a safe, reliable, and science-backed dairy brand, particularly in the premium infant formula category. Chinese consumers value Japanese-made dairy products for their quality control and rigorous safety protocols, which positions Morinaga strongly against local and international competitors.

Achievements and Recognition

  • Among the Top 5 Japanese dairy exporters to China
  • Morinaga’s lactoferrin-enriched formulas received clinical recognition for supporting infant immunity
  • Regular participation in China-based trade expos such as FHC Shanghai and CBME (Children Baby Maternity Expo)

Morinaga Milk Industry (Shanghai) Co., Ltd. plays a crucial role in adapting and delivering the parent company’s dairy and health innovations to one of the world’s most dynamic consumer markets, reinforcing its position as a trusted premium brand in Asia’s nutrition and wellness sector.